Helius Medical Technologies

Neurotech company (Nasdaq: HSDT)

Actualités connexes

Helius Raises $500M+ for SOL Treasury Launch with Pantera Capital

StockTitan_net 2025-09-15

Projets similaires

*Si ce n’est pas cliquable, cela signifie qu’aucune information détaillée n’est disponible.

Mega Matrix Inc.

US-listed companies focusing on blockchain finance and digital content(NYSE American: MPU)

Gryphon Digital Mining

Bitcoin mining company(NASDAQ: GRYP)

Sui Group Holdings

Non-bank lenders (NASDAQ: SUIG)

Tesla

Electric Vehicle and Energy Company(Nasdaq:TSLA)

BNB Network Company

E-cigarette manufacturing company(NASDAQ: BNC)

Ming Shing Group

Wet trades works services company(NAQ: MSW)

Anap Holdings Inc.

Japanese apparel retailer(3189.T)

Bitcoin Group SE

Acquisition Portfolio Companies (ADE.DE)

A propos de Helius Medical Technologies

Fondé2014

Helius is a leading neurotechnology company in the medical device field, specializing in utilizing non-implantable platform technologies to treat neurological deficits, enhance the brain's compensatory abilities, and promote neuroplasticity, thereby improving the lives of patients with neurological disorders. The company has announced the establishment of the SOL Treasury.

Communauté

Website

Étiquettes

Publicly listed company

Crypto Stocks

Trend of Hot Index Change

Membres de l'équipe

Dane C. Andreeff

President and Chief Executive Officer

Jeffrey S. Mathiesen

Chief Financial Officer

Investisseurs

Pantera Capital

Summer Capital

Détails du financement

Post-IPO(2025-09-14)

Montant：€434,85M

Investisseurs：